Cargando…
Bullous pemphigoid associated with ipilimumab therapy for advanced metastatic melanoma
Immunotherapy is now being routinely used in the management of many cancers. It is therefore vital that all clinicians are aware of the diverse array of cutaneous manifestations that can result from their use, which can vary from mild to life threatening.
Autores principales: | Hanley, T, Papa, S, Saha, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170966/ https://www.ncbi.nlm.nih.gov/pubmed/30302265 http://dx.doi.org/10.1177/2054270418793029 |
Ejemplares similares
-
Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid
por: Beck, Kristen M., et al.
Publicado: (2016) -
Semaglutide-associated bullous pemphigoid
por: Burruss, Clayton P., et al.
Publicado: (2021) -
Bullous pemphigoid associated with nintedanib
por: Hasson, Amelia M., et al.
Publicado: (2019) -
Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma
por: ERIKSSON, Hanna, et al.
Publicado: (2020) -
Bullous pemphigoid during ustekinumab therapy
por: Le Guern, Aurore, et al.
Publicado: (2015)